GCP
ACHV icon

GSA Capital Partners’s Achieve Life Sciences ACHV Stock Holding History

GSA Capital Partners’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-38,491
Closed -$327K – 1370
2021
Q3 		$327K Buy
+38,491
New +$302K 0.03% 956
2021
Q1 		– Sell
-10,129
Closed -$82K – 1055
2020
Q4 		$82K Sell
10,129
-14,861
-59% -$126K 0.01% 1112
2020
Q3 		$209K Buy
+24,990
New +$229K 0.03% 979

Other funds holding ACHV

SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

GSA Capital Partners's ACHV Position: Q4 2021 in Review

GSA Capital Partners sold out of Achieve Life Sciences (ACHV) in Q4 2021, closing a stake of 38,491 shares — an estimated $327K sold.

GSA Capital Partners first reported a position in ACHV in Q3 2020 and held it in 3 quarters. The position peaked at $327K in Q3 2021. 29 funds tracked by Wall St. Rank hold ACHV as of Q4 2021.

  • GSA Capital Partners reported no remaining Achieve Life Sciences position as of Q4 2021 after selling out during the quarter.
  • GSA Capital Partners sold 38,491 Achieve Life Sciences shares in Q4 2021, an estimated $327K.
  • GSA Capital Partners first reported a position in Achieve Life Sciences in Q3 2020 and held it in 3 quarters.
  • GSA Capital Partners's Achieve Life Sciences position peaked at $327K in Q3 2021.
  • 29 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q4 2021.

Based on GSA Capital Partners's 13F filing for Q4 2021, filed 14 Feb 2022.